These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18573776)

  • 1. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.
    Weedon-Fekjaer H; Lindqvist BH; Vatten LJ; Aalen OO; Tretli S
    J Med Screen; 2008; 15(2):83-90. PubMed ID: 18573776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
    Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
    J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
    Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
    Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening.
    Weedon-Fekjaer H; Tretli S; Aalen OO
    Stat Methods Med Res; 2010 Oct; 19(5):507-27. PubMed ID: 20356856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scheduling mammography screening for the early detection of breast cancer in Korean women.
    Lee SY; Jeong SH; Kim J; Jung SH; Song KB; Nam CM
    J Med Screen; 2007; 14(4):205-9. PubMed ID: 18078566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group.
    Straatman H; Peer PG; Verbeek AL
    Biometrics; 1997 Mar; 53(1):217-29. PubMed ID: 9147591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on scheduling periodic examinations for the early detection of breast cancer in Korea].
    Jeong SH; Kang DR; Hur NW; Kim J; Lee SY; Jung SH; Nam CM
    J Prev Med Public Health; 2006 Jul; 39(4):346-52. PubMed ID: 16910309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening.
    Jouve JL; Remontet L; Dancourt V; Lejeune C; Benhamiche AM; Faivre J; Esteve J
    Br J Cancer; 2001 Jun; 84(11):1477-81. PubMed ID: 11384097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
    Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
    Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of age-specific sensitivity and sojourn time in breast cancer screening studies.
    Cong XJ; Shen Y; Miller AB
    Stat Med; 2005 Oct; 24(20):3123-38. PubMed ID: 15977269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan.
    Hsieh HJ; Chen TH; Chang SH
    Stat Med; 2002 Nov; 21(22):3369-82. PubMed ID: 12407678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark.
    Bihrmann K; Jensen A; Olsen AH; Njor S; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2008; 15(1):23-6. PubMed ID: 18416951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
    Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
    Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a community-based intervention to enhance breast cancer screening practices in Brazil.
    Thuler LC; Freitas HG
    J Eval Clin Pract; 2008 Dec; 14(6):1012-7. PubMed ID: 18759754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme.
    Brown SB; Morrison DS; Cooke TG
    Breast Cancer Res Treat; 2009 Aug; 116(3):603-7. PubMed ID: 18855136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing interval breast cancer rates in Norway and North Carolina: results and challenges.
    Hofvind S; Yankaskas BC; Bulliard JL; Klabunde CN; Fracheboud J
    J Med Screen; 2009; 16(3):131-9. PubMed ID: 19805754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.